Volume 18, Number 11—November 2012
Dispatch
Seroprevalence of Influenza A(H1N1)pdm09 Virus Antibody, England, 2010 and 2011
Katja Hoschler
, Catherine Thompson, Nick Andrews, Monica Galiano, Richard Pebody, Joanna Ellis, Elaine Stanford, Marc Baguelin, Elizabeth Miller, and Maria Zambon
, Catherine Thompson, Nick Andrews, Monica Galiano, Richard Pebody, Joanna Ellis, Elaine Stanford, Marc Baguelin, Elizabeth Miller, and Maria Zambon
Table 2
Seroincidence estimates of influenza A(H1N1)pdm09 virus antibody, England, 2010 and 2011
| Age group, y | Change in antibody level, % (95% CI) |
||||
|---|---|---|---|---|---|
| Post–second wave to pre–third wave* |
Pre–third wave to post–third wave† |
||||
| Hemagglutination inhibition | Microneutralization | Hemagglutination inhibition | Microneutralization | ||
| <5 | 15 (3–27) | 10 (–3 to 24) | 10 (0–21) | 11 (1–22) | |
| 5–14 | –4 (–13 to 5) | 0 (–11 to 11) | 19 (11–28) | 9 (1–18) | |
| 15–24 | –7 (–16 to 3) | –5 (–15 to 6) | 30 (23–37) | 21 (14–29) | |
| 25–44 | –4 (–12 to 4) | –7 (–18 to 5) | 35 (28–42) | 24 (16–31) | |
| 45–64 | –5 (–13 to 2) | –9 (–19 to 1) | 23 (15–33) | 9 (0–19) | |
| 65–74 | –4 (–13 to 5) | –6 (–18 to 6) | 31 (18–43) | 26 (13–39) | |
| >75 | –15 (–25 to –4) | –20 (–32 to –8) | 48 (34–61) | 28 (13–42) | |
*Antibody levels at the end of the 2009–10 winter season compared with those before the 2010–11 season.
†Antibody levels before and after the 2010–11 season.
Page created: October 05, 2012
Page updated: October 05, 2012
Page reviewed: October 05, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.